Amgen Inc.
AMGN Healthcare Drug Manufacturers General
Amgen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $36.8 billion, up 9.95% from fiscal 2024. In the quarter to June 2026, revenue grew 9.53%, EPS grew 65.4%, free cash flow grew 82.6% and total debt rose 1.96%, each against the same quarter a year earlier. Member of the S&P 500, Nasdaq 100 and Dow Jones; dividend growth for ten consecutive years, revenue growth for five.
Follow AMGN
Amgen Inc. (AMGN) Gross margin
Amgen Inc.'s gross margin over the twelve months to 30 June 2026 was 69.5%, up 2.3 percentage points from fiscal 2025 (67.3%). Over the past ten years it has ranged from 61.5% (fiscal 2024) to 82.7% (fiscal 2018); the current reading is higher than 18% of that period. That is in line with the Drug Manufacturers General industry median of 72.8% and above the Healthcare sector median of 53.5%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 67.3% | 5.72 |
| FY2024 | 61.5% | (8.49) |
| FY2023 | 70.0% | (5.64) |
| FY2022 | 75.7% | 0.50 |
| FY2021 | 75.2% | (0.61) |
| FY2020 | 75.8% | (5.58) |
| FY2019 | 81.4% | (1.38) |
| FY2018 | 82.7% | 0.54 |
| FY2017 | 82.2% | 0.29 |
| FY2016 | 81.9% | 1.41 |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Jun 2026 | 72.0% | 3.88 |
| Mar 2026 | 68.2% | (1.68) |
| Dec 2025 | 69.8% | 2.09 |
| Sep 2025 | 67.8% | 0.55 |
| 42 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| AZN AstraZeneca PLC compare | 81.9% |
| NVO Novo Nordisk A/S compare | 80.7% |
| GILD Gilead Sciences, Inc. compare | 79.6% |
| NVS Novartis AG compare | 74.7% |
| PFE Pfizer Inc. compare | 73.2% |
| MRK Merck & Co., Inc. compare | 73.0% |
| ABBV AbbVie Inc. compare | 71.5% |
| BMY Bristol Myers Squibb Company compare | 70.2% |
| AMGN Amgen Inc. | 69.5% |
| Drug Manufacturers General industry median | 72.8% |
| Healthcare sector median | 53.5% |
| Market median | 46.2% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on AMGN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement